HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $222,000 | -50.8% | 2,010 | -47.1% | 0.00% | -50.0% |
| Q4 2020 | $451,000 | +68.3% | 3,798 | +23.4% | 0.00% | +100.0% |
| Q3 2020 | $268,000 | -20.0% | 3,077 | -8.6% | 0.00% | -50.0% |
| Q1 2020 | $335,000 | -31.2% | 3,367 | -20.4% | 0.00% | 0.0% |
| Q4 2019 | $487,000 | -6.5% | 4,232 | +2.5% | 0.00% | -33.3% |
| Q3 2019 | $521,000 | +23.5% | 4,129 | +17.8% | 0.00% | +50.0% |
| Q2 2019 | $422,000 | -11.7% | 3,504 | -76.3% | 0.00% | -33.3% |
| Q3 2015 | $478,000 | -68.8% | 14,810 | -60.0% | 0.00% | -66.7% |
| Q2 2015 | $1,531,000 | -27.7% | 37,004 | -21.6% | 0.01% | -30.8% |
| Q1 2015 | $2,119,000 | +3.7% | 47,174 | -13.6% | 0.01% | 0.0% |
| Q4 2014 | $2,043,000 | +6.0% | 54,582 | -1.1% | 0.01% | +8.3% |
| Q3 2014 | $1,928,000 | +108.7% | 55,212 | +110.9% | 0.01% | -69.2% |
| Q2 2014 | $924,000 | +8.3% | 26,180 | 0.0% | 0.04% | +11.4% |
| Q1 2014 | $853,000 | -22.7% | 26,180 | 0.0% | 0.04% | -23.9% |
| Q4 2013 | $1,103,000 | – | 26,180 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |